They do have some great medicines, that isn't the issue here really is it. It cost far more than they could handle, and they should have focussed on a couple meds first but it looks like they threw $$ into so many baskets and didn't get to market in time to make it all balance. I hope Mercer keep funding them to get to the point where the drugs they have made successfully reap some benefits and become sort after. That would be a good outcome here... some better news is that the debt we have isn't that significant, so it all depends on sales.... I do hope they can come back strong again... maybe wishful thinking, but they were the first Aus company to establish CBD meds, and I remember how much they had to go through to get the growing licences and jump through the hoops of the governing bodies... at this point, all we can do is pray!
- Forums
- ASX - By Stock
- RGT
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-17
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.5¢ |
Change
0.010(2.90%) |
Mkt cap ! $17.18M |
Open | High | Low | Value | Volume |
35.0¢ | 36.0¢ | 34.5¢ | $6.75K | 18.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1885 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1885 | 0.290 |
1 | 2200 | 0.230 |
1 | 20000 | 0.225 |
1 | 4545 | 0.220 |
2 | 6011 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 100 | 1 |
0.380 | 79 | 1 |
0.400 | 1090 | 3 |
0.420 | 23 | 1 |
0.430 | 28 | 1 |
Last trade - 13.02pm 27/09/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |